334 results
Page 2 of 17
8-K
EX-99.1
bq9 7uipdr1y0
22 Dec 23
Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics
4:15pm
8-K
EX-1.1
iu18hjhllu
13 Nov 23
Other Events
4:19pm
424B5
h0gead0zq 0c592i1n8
1 Nov 23
Prospectus supplement for primary offering
4:16pm
424B3
bqffhyyugj7fco
30 Oct 23
Prospectus supplement
8:05am
8-K
EX-99.2
f8ci72 5g2
26 Oct 23
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
7:44am
8-K
EX-99.1
kjstafe8
26 Oct 23
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
7:44am
DFAN14A
5f4qm30n cwj
10 Oct 23
Additional proxy materials by non-management
6:48am
8-K
EX-99.2
c8b77adqog4un8
27 Jul 23
Bristol Myers Squibb Reports Second Quarter Financial Results for 2023
7:50am
8-K
EX-99.1
0jjsvae 95e
27 Jul 23
Bristol Myers Squibb Reports Second Quarter Financial Results for 2023
7:50am
8-K
EX-99.2
jphct7fyon gj49ojn
27 Apr 23
Bristol Myers Squibb Reports First Quarter Financial Results for 2023
7:45am
8-K
EX-99.1
w02q8iacl9xy
27 Apr 23
Bristol Myers Squibb Reports First Quarter Financial Results for 2023
7:45am
DEFA14A
agujsl4apg
26 Apr 23
Additional proxy soliciting materials
4:38pm
8-K
EX-99.1
jrih6t2bohiddsc3wto
26 Apr 23
Bristol Myers Squibb Announces Leadership Transition Plan
4:35pm
DEFA14A
yko6niy 7x0
10 Apr 23
Additional proxy soliciting materials
5:12pm
8-K
EX-99.1
zcdy41yvczz5 53ddj
26 Oct 22
Bristol Myers Squibb Reports Third Quarter Financial Results for 2022
7:48am
8-K
EX-99.3
hutlep80f9c8d7efu
26 Oct 22
Bristol Myers Squibb Reports Third Quarter Financial Results for 2022
7:48am